, which eliminates the m 1 A misincorporation and truncation patterns, and (3) reverse transcription using either a highly processive reverse transcriptase (TGIRT) with a greater tendency to lead to misincorporations at m 1 A sites 5, 6 
1
A sites are converted to N 6 -methyladenosine (m 6 A) 2, 4 , which eliminates the m 1 A misincorporation and truncation patterns, and (3) reverse transcription using either a highly processive reverse transcriptase (TGIRT) with a greater tendency to lead to misincorporations at m 1 A sites 5, 6 , or a less processive one (SuperScript III (SS)) tending to lead to premature truncations ( Fig. 1a and Supplementary Note 1).
We applied m 1 A-seq-SS and m 1 A-seq-TGIRT to RNA derived from HEK293T cells. Each dataset included samples sequenced either directly ('input'), or following m 1 A-immunoprecipitation ('IP'), or following both m 1 A-IP and Dimroth rearrangement ('IP + Dimroth'). We enhanced these two datasets with 8 input and IP sample pairs from ref. 2, and 14 sample pairs from ref. 1. These experimental datasets collectively comprised an unprecedented depth of more than 2 billion reads (Supplementary Table 1 ). We developed a single, common analytical pipeline to identify m 1 A-specific misincorporation profiles, relying on statistical tests assessing whether misincorporation rates were significantly higher in (1) IP samples, compared with input, or (2) IP compared with IP + Dimroth. In addition, we required putatively modified sites to have at least two distinct types of misincorporation (for example, A→ T and A→ G), and used the reverse transcriptase truncation rate as an optional filter (Extended Data Fig. 1a and Methods). Collectively, we identified 205 high-confidence putative m 1 A sites, and 72 additional lower-ranking ones (Fig. 1b-e and Supplementary Table 2 ). Quantifications of reverse transcriptase truncation and misincorporation levels were highly reproducible among replicates (Extended Data Fig. 1b-d) . Each site was detected, on average, in approximately 11 independent samples (interquartile range 8-16), and 115 sites were independently identified in at least 2 datasets (Fig. 1b, c) . As expected, use of TGIRT-based m 1 A-seq led to higher misincorporation and lower truncation rates at the detected sites compared with the SuperScript-based libraries (Extended Data Fig. 1e , f); IPs highly enriched for misincorporation rates, and Dimroth rearrangement reduced them (Extended Data Fig. 1g, h ). We established our approach as highly sensitive and specific, as it allowed . Surprisingly, our dataset comprised predominantly well-established sites in rRNA and tRNA (Fig. 1c) , and only 15 sites in mRNA and long non-coding RNAs (lncRNAs), 10 of which were in cytosolic transcripts and 5 in mitochondria (Fig. 1d) . Most sites had very low misincorporation rates (less than 2.5%) in the absence of antibodymediated enrichment (Fig. 1d) , suggesting that they are modified at low stoichio metries. Two notable exceptions, both previously shown to harbour RNA:DNA sequencing differences of unknown nature, were in (1) tRNA-like mascRNA (MALAT1-associated small cytoplasmic RNA) 7 and (2) mitochondrially encoded ND5 transcript 8, 9 (Supplementary Note 3). Misincorporation levels at the detected mRNA sites in the cytosol across thousands of samples from more than 50 tissues in the Genotype-Tissue Expression (GTEx) collection 10 similarly revealed very low misincorporation levels, but high levels in rRNAs and in mascRNA serving as controls (Extended Data Fig. 2 and Supplementary Note 4), suggesting that the low m 1 A levels are not specific only to tumorous cell lines. We further exclude the possibility that the low number of sites in mRNAs is due to decreased detection power in mRNAs that are less expressed (Supplementary Note 5 and Extended Data Fig. 3a, b ). In addition, we observe the previously described 5′ -biased distribution of m Table 3) , but find no m 1 A-specific misincorporation profiles within these regions (Supplementary Note 5). It remains to be established whether these enrichments originate from complex modification patterns at the first transcribed nucleotide, or are experimental artefacts. Thus, with few exceptions, m 1 A is rarely observed at internal sites on mRNA, and typically at low stoichiometry.
All sites in cytosolic mRNAs and in Malat1 mascRNA comprised a single motif, or slight deviations thereof, consisting of the sequence Letter reSeArCH GUUCNANNC (A = m 1 A) within a strong hairpin structure typically comprising a 5-base pair (bp) stem and a 7-bp loop ( Fig. 2a ; see also Supplementary Note 6 and Extended Data Fig. 5a, b) . This sequence and structural motif is identical to the T-loop of tRNAs, where m 1 A at position 58 is catalysed by the TRMT6/TRMT61A complex at precisely the same relative position 11, 12 . Consistently, knockdown of TRMT6/TRMT61A resulted in elimination of m 1 A from T-loop harbouring mRNAs (Extended Data Fig. 5c ). Conversely, overexpression of TRMT6/TRMT61A followed by m 1 A-seq-TGIRT markedly increased misincorporation rates at the detected sites (Fig. 2b) , and led to accumulation of m 1 A at 384 cytosolic mRNA and lncRNA sites (Fig. 2c  and Supplementary Table 4) , a massive enrichment with respect to the 10 originally identified sites. The GUUCNANNC motif was highly enriched at these sites (present in 193 out of 384 sites) (Fig. 2d ), which were further enriched for a stable T-loop-like structure (Fig. 2e) , typically consisting of a 7 bp loop (Extended Data Fig. 5d ) and a 6-7 bp stem (Extended Data Fig. 5e ). A subset of the peaks could be further validated by seeking m 1 A sites that had converted to m 6 A following Dimroth treatment of mRNA extracted from TRMT6/TRMT61A-overexpressing cells (Supplementary Note 7 and Extended Data Fig. 6a-e) . To directly explore the determinants of specificity of TRMT6/TRMT61A, we used a plasmid library comprising thousands of T-loop sequences and systematically mutated counterparts 13 , all cloned as 3′ untranslated region (UTR) elements downstream of a 
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reporter. Co-transfection of this plasmid pool with TRMT6/TRM61A into HEK293T cells allowed reconstitution of the m 1 A misincorporation signal precisely at the predicted position (Fig. 2f) . Systematic point-mutation of each position in the GUUCNANNC motif allowed functionally reconstruction of the consensus required for modification via the TRMT6/TRMT61A complex (Fig. 2g) , highlighting requirements for G-C base pairing at positions − 5 and + 3, and the requirements for a pyrimidine, a cytosine, and a purine at positions − 3, − 2 and − 1, respectively. Systematic structural mutants and compensatory mutations demonstrated direct dependency of misincorporation on stem stability (Fig. 2h ). These analyses demonstrate that within the cytosol, m 1 A is catalysed at T-loop-like elements via TRMT6/ TRMT61A.
We next focused on the site in the mitochondrially encoded ND5 gene, harbouring the highest levels of modification in our dataset, with misincorporation rates of approximately 25% in polyadenylated RNA (poly(A) mRNA) from HEK293T cells (Supplementary Note 8) . The absence of misincorporations in reads from the transcribed antisense strand (Extended Data Fig. 7a ) and in DNA (Extended Data Fig. 7b ) ruled out DNA heteroplasmy as their source. Misincorporation levels in ND5 RNA across thousands of GTEx samples were highly tissue specific: essentially absent in muscle and in heart but approximately 30% (median) in ovary and pituitary gland (Fig. 3a) . Targeted sequencing of the ND5 locus in human muscle and ovary samples confirmed these findings (Fig. 3b) . The relatively high m 1 A levels observed in the human ovary samples prompted an exploration of ND5 methylation in development. Strikingly, single-cell RNA-seq (scRNA-seq) from 1,529 individual cells 14 revealed misincorporation levels greater than 75% at the eight-cell stage (Fig. 3c) , roughly equivalent to those observed in 16S rRNA, which was previously shown to be methylated at nearly 100% stoichiometry 15 . Levels of misincorporation decreased with developmental progression, and by day 7 reached approximately 12.5% (Fig. 3c) . scRNA-seq analysis of 124 single cells, spanning a wider developmental range 16 , extended these findings, and revealed that from the metaphase II oocyte to the four-cell embryo, methylation levels at ND5 are probably close to 100% ( Fig. 3d and Supplementary Note 9) followed by a precipitous decrease (Fig. 3d) . As zygotic mitochondrial transcription begins around the eight-cell developmental stage 17 , we speculated that m 1 A might mark particularly stable maternal transcripts that persist up to zygotic mitochondrial transcription. Indeed, transcriptional arrest in HEK293T cells using actinomycin D or ethidium bromide led to an approximately fourfold increase in ND5 misincorporation levels ( Fig. 3e and Extended Data Fig. 7c, respectively) , confirming the association between ND5 stability and methylation. Thus, m 1 A in ND5 is highly tissue-and developmentally specific, and may serve as a mark of a subset of ND5 transcripts, which are maternally inherited and dominate until zygotic mitochondrial transcription at roughly the eight-cell stage.
We hypothesized that m 1 A in ND5 is catalysed by TRMT10C, which catalyses methylation at position 9 of mitochondrial tRNAs 18 . Indeed, TRMT10C knockdown led to almost complete abolition of methylation at ND5:1374; TRMT10C overexpression resulted in a 50% increase in methylation levels (Fig. 3f) . Analysis of the GTEx data revealed that ND5 methylation levels are under genetic control, as they are strongly correlated across different tissues from the same individual (Extended Data Fig. 7d, e) . Detailed analysis revealed a relatively common single nucleotide polymorphism (SNP) (G13708A) two bases upstream of the ND5 site (at 13710), severely reducing the ability of ND5 to undergo methylation (Fig. 3g) . Targeted sequencing of the ND5 locus in lymphoblastoid cell lines from individuals harbouring this SNP compared with controls confirmed these results (Extended Data Fig. 7f ). G13708A is among the defining SNPs of the Eurasian J haplogroup, and is thought to affect the clinical expression of Leber hereditary optic neuropathy ; in this study the authors used SuperScript III for reverse transcriptase. e, Misincorporation levels at ND5:1374 measured at the indicated time-points following actinomycin-D-mediated transcriptional arrest (n = 3). f, Misincorporation levels at ND5:1374 in HEK293T cells after overexpression (OE) of TRMT10C, treatment with short interfering RNAs (siRNAs) directed against TRMT10C (siTRMT10C), or treatment with a control siRNA. Error bars, binomial confidence interval based on a single, representative replicate. g, Misincorporation levels at ND5:1374 across 102 samples from human ovaries, colour-coded on the basis of the presence of a SNP at position 13708 (red, wild type; blue, SNP). 
Figure 4 | m 1 A-containing mRNAs are inefficiently translated. a, Misincorporation rates at the ND5 locus across the polysomal fractions, measured using strand-specific targeted sequencing (n = 3). Dots, measurements; red bar, mean. b, Misincorporation rates at four selected loci following overexpression of TRMT6/ TRMT61A, measured across four polysomal fractions (n = 3), displayed as in a. c, Depiction of the four designed variants, perturbing either the modified site or the secondary structure, on the basis of the methylated site in the PRUNE gene. The methylated position is plotted in red, the perturbed position in magenta. d, Misincorporation percentages at the designed site, quantified across the four constructs using targeted sequencing (n = 3). Dots, measurements; red bar, mean. Note that for the 'site mutation' variant the misincorporation rate reflects the fraction of reads not harbouring a 'T' , in contrast to all remaining variants in which it reflects the fraction not harbouring an ' A' . e, Renillanormalized firefly luciferase levels in TRMT6/ TRMT61A-overexpressing cells divided by the corresponding ratio in non-overexpressing control for the four tested constructs. Dots, measurements; red bars, mean. Presented are t-test-based P values.
We speculated that the Watson-Crick disruptive nature of m 1 A would prevent effective translation of modified codons. Polysome fractionation experiments revealed a substantial and highly significant reduction in misincorporation levels in ND5 in the heavier fractions relative to lighter ones (Fig. 4a and Extended Data Fig. 8a ), suggesting repressed translation of m 1 A-harbouring transcripts. Consistently, upon overexpression of TRMT6/TRMT61A, we found a pronounced and highly significant depletion of m 1 A-modified mRNA in the ribosome-heavy fractions relative to the ribosome-poor fraction (Fig. 4b) . This was observed for cytosolic sites that were present either in the 5′ UTR or within the coding DNA sequence (CDS), but not for a site present in the 3′ UTR (Fig. 4b) . We next cloned a 60 bp region harbouring the m 1 A sites in the PRUNE gene in-frame and upstream of a firefly luciferase coding region (Fig. 4c) . Co-transfection of this construct with TRMT6/TRM61A led to high m 1 A levels (Fig. 4d) , which were eliminated upon disrupting the sequence or structure, but restored via a compensatory structural mutation (Fig. 4c, d) . The point-mutation of the m 1 A site in PRUNE or structural disruption led to an approximately twofold increased luciferase levels compared with the sequences harbouring intact consensus sequences and T-loop structures (Fig. 4e) . Conversely, no decrease-and even a slight increase (P = 0.03)-was observed when introducing the wild-type element into the 3′ UTR upon overexpression of TRMT6/TRMT61A compared with controls (Extended Data Fig. 8b-d) . The consistent translational repression associated with m 1 A sites within the 5′ UTR or CDS, but not in the 3′ UTR, suggests that it may be dependent on ribosomal scanning or translation (Supplementary Note 10 and Extended Data Fig. 9) .
Collectively, the ability to map and quantify m Supplementary Information is available in the online version of the paper.

MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cell culture for knockdown and overexpression experiments. Human HEK293T cells (American Type Culture Collection (ATCC); passage numbers 5-15; no further verification of cell line identity was performed, but the cells screened negatively for mycoplasma) were plated in six-well plates at 20% confluency. siRNAs targeting TRMT10C (Thermo Fisher s29784), TRMT6 (s28400), and TRMT61A (s41859) were transfected using Lipofectamine RNAiMAX (Life Technologies AB4427037) following the manufacturer's protocols, with two siRNA boosts with a 48 h interval between them; siRNA targeting TRMT6/TRMT61A was co-transfected with half of the recommended amount of siRNA targeting TRMT6 and the other half targeting TRMT61A. As negative controls, we used Ambion In Vivo Negative Control #2 siRNA (catalogue number 4390846). Cells were harvested at 96 h. For overexpression, plasmids encoding full-length TRMT6/ TRMT61A under a cytomegalovirus promoter were obtained from OriGene. The plasmids were transfected into HEK293T cells using PolyJet (SignaGene) with one boost of the plasmid at 24 h. Cells were harvested 48 h after transfection. Blocking transcription or translation. Transcription was blocked using actinomycin D (Sigma) at a concentration of 10 μ g ml −1 or ethidium bromide (Amresco) at a concentration of 0.4 μ g ml −1
. Translation was blocked using cycloheximide (Sigma) at concentration of 100 μ g ml −1
. Human RNA. Total RNA extracted from ovary and muscles from a human donor was obtained from Takara. Lymphoblastoid cell lines were obtained from Coriell. RNA preparation for m 1 A-seq. RNA was extracted from cells using NucleoZOL (Macherey-Nagel). Enrichment of poly(A) + RNA from total RNA was performed using Oligo(dT) Dynabeads (Invitrogen) according to the manufacturer's protocol. The mRNA was chemically fragmented into approximately 100-nt-long sections using RNA fragmentation reagent (Ambion). The sample was cleaned using Dynabeads (Life Technologies), and resuspended in 20 μ l IPP buffer (150 mM NaCl, 0.1% NP-40, 10 mM Tris-HCl, pH 7.5). m 1 A-seq and m 6 A-seq. The protocol we developed for transcriptome-wide mapping m 1 A is based on our previously published protocol for mapping N 6 -methyladenosine (m 6 A) 31 . Briefly, 40 μ l of protein-G magnetic beads were washed and resuspended in 200 μ l of IPP buffer, and tumbled with 5 μ l of affinitypurified anti-m 1 A polyclonal antibody (MBL) at room temperature for 30 min. RNA was added to the antibody-bead mixture, and incubated for 2 h at 4 °C. The RNA was then washed twice in 200 μ l of IPP buffer, twice in low-salt IPP buffer (50 mM NaCl, 0.1% NP-40, 10 mM Tris-HCl, pH 7.5), and twice in high-salt IPP buffer (500 mM NaCl, 0.1% NP-40, 10 mM Tris-HCl, pH 7.5), and eluted in 30 μ l RLT (Qiagen). To purify the RNA, 20 μ l of MyOne Silane Dynabeads (Life Technologies) were washed in 100 μ l RLT, resuspended in 30 μ l RLT, and added to the eluted RNA. Sixty microlitres of 100% ethanol were added to the mixture, the mixture attached to the magnet, and the supernatant discarded. After two washes in 100 μ l of 70% ethanol, the RNA was eluted from the beads in 10 μ l of H 2 O. Dimroth rearrangements were performed as described in ref. A RNA-seq libraries were generated on the basis of the protocol described in refs 32, 33. Briefly, RNA was first subjected to FastAP Thermosensitive Alkaline Phosphatase (Thermo Scientific), followed by a 3′ ligation of an RNA adaptor using T4 ligase (New England Biolabs). Ligated RNA was reverse transcribed either using SuperScript III (Invitrogen) or TGIRT-III (InGex), and the cDNA was subjected to a 3′ ligation with a second adaptor using T4 ligase. The single-stranded cDNA product was then amplified for 9-12 cycles in a PCR reaction. Libraries were sequenced on Illumina Nextseq platforms generating short paired-end reads, ranging from 25 to 55 bp from each end. Identification of putative m 1 A sites. A human reference genome was generated on the basis of the hg19 assembly of the human genome, supplemented with tRNA, rRNA, and snRNAs, obtained from the modomics database 34 . Non-enriched (input), m A-enriched (IP + Dimroth) samples were aligned to the genome, using STAR aligner 35 with an increased stringency allowing only up to three mismatches per each read pair ('-outFilterMismatchNmax 3′ ). All duplicates were marked using picard tools MarkDuplicates.jar' , and non-primary alignments were removed. The identity of each nucleotide at each genomic position was extracted using 'samtools mpileup' , with max per-file depth settings of '-d 100000' . A custom script was used to parse the pileup format into a tabular format summarizing the abundance of each nucleotide at each position. All positions harbouring an ' A' in the annotated sense strand, with at least two mismatches, occurring in at least 10% of the reads overlapping it were recorded. All sites, recorded across any replicates and any of the samples, were pooled into a single data set. Misincorporation rates at each of these pooled sites were subsequently re-extracted for each of the experiments (allowing analysis of each site in each experiment, even if they did not pass the initial thresholds in that particular experiment). A bona fide m 1 A site is expected to have higher mismatch rates in IP compared with input, and lower levels in IP + Dimroth compared with IP. Hence, we used a χ 2 test on the basis of the aggregated misincorporation counts (across replicates) to test the hypotheses that (1) the number of mismatches in the IP sample was higher than input, and (2) the number of mismatches in IP was higher than in IP + Dimroth. The following criteria were then used for identification of putative m 1 A sites: (1) at least one of the two calculated P values was significant (P < 0.05); (2) the product of the P values was less than 0.01; (3) a difference in misincorporation rate between the sample with the lowest levels of misincorporation and the highest level of at least 0.2; (4) the sites had to be covered by at least ten reads in at least two samples; (5) at least 1% of all reads mapping to the site (across all replicates and samples) had to be ' A' , at least 1% of all reads mapping to the site (across all replicates and samples) had to be 'T' , and at least 1% of all reads mapping to the site (across all replicates and samples) had to be 'C' or 'G' . These last criteria were set to aid in the discrimination of SNPs (where only one alternative to an ' A' is expected) from m 1 A sites (where typically more than one type of misincorporation is observed). Sites harbouring identical sequences in a 24 bp window (12 bp upstream + 11 bp downstream) surrounding the putative site were filtered, to retain only one. Nonetheless, owing to merging of sites from different data sets and the multiple loci from which identical or nearly identical tRNAs were transcribed, a subset of duplication was retained-and are flagged as such-within tRNA entries in Supplementary Table 2 .
This pipeline was applied to four batches of samples: (1) input, IP, and IP + Dimroth (two replicates each) to which we applied m The 'high-confidence' data set of 205 sites comprised all sites for which at least two significant P values were obtained across any of the comparisons performed across any of the data sets; the 'low confidence' sites comprised all sites associated with a single significant P value. Of note, to accommodate the distinct experimental design in the data sets obtained from refs 1, 2, we adapted the precise sets of comparisons that were performed by the analytical pipeline. Specifically, in addition to assessing whether IP differed from input, and from IP + Dimroth, in the ref. 2 data set we further derived χ 2 -based P values to assess whether the Dimroth rearrangement in the input samples led to reduced mismatch levels compared with in its absence. In the data set produced in ref. 1, the authors did not use a Dimroth rearrangement, but instead relied on treating the RNA with AlkB, an Escherichia coli-derived demethylase that eliminates m 1 A. Reference 1 further compared measurements upon knockout of AlkBH3, which they found to demethy late m 1 A. Accordingly, we performed four statistical tests, examining differences in mutation rates between (1) IP versus input in wild-type samples, (2) IP versus input across stress conditions (H 2 O 2 , starvation), (2) IP versus IP + AlkB, and (3) IP in wild-type cells versus IP in ALKBH3 knockout cells. Of note, given that any site passing any of the statistical tests was considered a putative site, effectively our criteria for identifying putative m 1 A sites in the data sets of refs 1, 2 are more lenient than the criteria we applied for the two data sets we generated. Finally, in the data set generated upon overexpression of TRMT6/TRMT61A, we did not perform Dimroth rearrangements; instead we performed two tests, examining differences in misincorporation rates between (1) input samples and IP samples, and (2) input samples following overexpression of TRMT6/TRMT61A compared with controls. All analyses were performed using the identical computational pipeline, into which we fed, as parameters, the precise comparisons to be made.
Although our m 1 A-seq approach provides strand-specific data, in the initial analyses in Figs 1 and 2 strand specificity was inferred from the genomic annotation rather than the read. This allowed application of an identical pipeline to the data generated in this study and the two previously published data sets. To analyse m 1 A at the ND5 locus, we subsequently called mutations in a strand-specific manner (separately inferring mutations on the + and − strands), to prevent dilution of misincorporation signal from the antisense strand. Quantification of reverse transcriptase truncations. For each of the putatively identified m 1 A sites, we calculated the rate of transcription termination at position + 1 with respect to the site. This was performed by first artificially merging all read pairs into a single, artificial read extending from the beginning of one read to the end of its mate, and then using bedtools to count the number of reads beginning and overlapping each position. The ratio between the two was defined as the stop rate at that position, as performed in ref. 23. Identification of m 1 A peaks. Peak detection was performed on the basis of our previously published approach for detecting peaks in m 6 A-seq data 31, 36 . Specifically, an in-house script was first used to project all reads aligning to the genome upon the human transcriptome. Only reads fully matching a transcript structure, as defined by the 'UCSC Known Genes' transcriptome annotation, were retained. Such reads were computationally extended in transcriptome space from the beginning of the first read to the end of its mate, and coverage in transcriptome space was calculated for each nucleotide across all transcripts.
Putative m 1 A sites were identified using a three-step approach, as follows. (1) Peak detection within genes. To search for enriched peaks in the m 6 A IP samples, we scanned each gene using sliding windows of 100 nt with 50-nt overlaps. Each window was assigned a peak over median (POM) score, defined as mean coverage in the window/median coverage across the gene. Windows with POM scores greater than 4 (that is, greater than fourfold enrichment) and with a mean coverage of more than ten reads were retained. Overlapping windows were merged together, and for each disjoint set of windows in transcriptome space we recorded its start, end, and peak position, corresponding to the position with the maximal coverage across the window. (2) Ensuring that peaks were absent in input. We repeated the procedure in step 1 for the input sample. We eliminated from all subsequent analysis all windows that were detected in both steps 1 and 2. (3) Comparison of multiple samples. To search for consistently occurring peaks across different samples, we first merged the coordinates of all windows from all samples passing steps 1 and 2, to define a set of disjoint windows passing these filters in at least one of the samples. For each such window, we recalculated the peak start, end, peak position, and POM score (as defined above) across each of the samples using the approach in step 1. In addition, for each window we calculated a peak over input (POI) score, corresponding to the fold change of coverage across the window in the IP sample over the coverage in the input sample. To account for differences in sample depth, we estimated the mean difference between IP and input samples across the 500 most highly expressed genes, which we used as an estimate for background. We subtracted this background from the POI score.
On the basis of careful examination of the peaks at the beginning of transcripts, which revealed that in many cases the peaks originated from the first transcribed nucleotide, we used the approach we described in ref. 36 . Briefly, this approach relies on calculating the fold change upon m 1 A-IP, compared with input, in reads beginning at each of the first 50 annotated positions in each transcript. For the analysis displayed in Extended Data Fig. 4d , we first calculated these ratios across the set of SuperScript IP and input samples. We then integrated the quantifications of fold changes by extracting the maximum fold change per position per transcript. We then quantified the proportion of pileups harbouring an ' A' as a function of this fold change, revealing that pileups beginning with an ' A' were more frequent at the higher-confidence sites, harbouring stronger fold changes. mRNA expression analysis. To estimate expression levels, reads were aligned against the human genome using RSEM (version 1.2.31) with default parameters 37 . For robust comparison between different samples, we used trimmed mean of M values (TMM) normalization of the RSEM read counts 38 as implemented by the edgeR package 39 in R. Prediction of RNA secondary structure. For predicting secondary structure in the region surrounding putative m 1 A sites, we extracted a sequence window of 24 bp, including 12 bp upstream of the modified site and 11 bp downstream. Free-energy calculations and predicted secondary structures were calculated using RNAfold version 2.1.5. The secondary structures were subsequently parsed, using an in-house script, to quantify the stem and loop lengths (Fig. 2) . Massively parallel reporter assay. The design and cloning of the massively parallel reporter assay library into a plasmid were described in ref. 13 . A 10 cm plate of HEK293T cells was transiently transfected with equal amounts of TRMT6, TRMT61A, and the library plasmid using PolyJet (SignaGene). RNA was purified using NucleoZOL reagent (Macherey-Nagel). Sequence-specific m 1 A-seq-TGIRT was performed on total RNA essentially as described in ref. 13, except reverse transcription from the constant sequence stemming from the library plasmid (AGCATTAACCCTCACTAAAGGGAAAGG) was done using TGIRT-III (InGex). Adaptor ligation and PCR enrichment with an inner-plasmidspecific primer (GGTCCGATATCGAATGGCGC) were performed as previously described 13 . Alignment of the massively parallel reporter assay data was performed as previously described 13 . To quantify misincorporations we used 'samtools mpileup' , as described above. For the sequence logo depicted in Fig. 2j , we first extracted the 75th percentile of misincorporation rates following point-mutation of each of the indicated sites across each of the assayed 74 T-loops into each of the 4 nucleotides. For each position, this value was then divided by the sum of this value across all four nucleotides, to yield 'relative misincorporation rate' (summing up to 1, at each position). The height of each nucleotide at each position was then plotted in direct proportion to its relative misincorporation rate. Annotation of mitochondrial and tRNA sites. All reads were aligned to the chrM assembly forming part of the human hg19 assembly, and the Supplementary Tables provide positions with respect to it. For consistency with the mitochondrial community, within the manuscript we refer to positions with respect to the slightly more updated chrM_rCRS assembly. For tRNAs, we refer to all positions in the figures on the basis of the standard tRNA nomenclature (so that the anticodon nucleotides are always numbered 34-36, and the T-loop between positions 54 and 60). Quantification of misincorporation in GTEx and single-cell RNA-seq data. Raw fastq files were obtained for each of the files in these data sets, and aligned using STAR (as above). Mpileup was applied to quantify misincorporation levels across the positions detected in this study. For Fig. 4c, d , we filtered out all single cells in which an SNP was observed at position 13708, as this SNP severely reduces methylation. An SNP was called in this position, on the basis of the RNA-seq data, if more than 80% of the reads corresponded to the SNP nucleotide. Polysome fractionation. Polysome fractionation was done as specified in ref. 40 , with one exception: we used 10-50% sucrose gradient instead of 5-50%. A levels at specific loci, reverse transcription was done on 1 μ g of RNA using random hexamers and TGIRT-III (InGex) reverse transcriptase. Amplicons were PCR amplified using a nested PCR approach, involving a first amplification step with gene-specific primers and a partial Illumina adaptor tail, and a second amplification leading to the incorporation of the full-length Illumina adapters. For ND5 amplicons, reverse transcription was done using a strand-specific primer instead of random hexamers, to avoid contamination by the ND5 antisense transcript. The resultant amplicon was amplified with primers including the full-length Illumina adapters in a single step. All primers can be found in Supplementary Table 5 . Luciferase assay. For the luciferase experiments, two plasmids were used: (1) pGL4.73, for expression of Renilla luciferase under an SV40 promoter, and (2) a plasmid encoding an ATG start codon followed by 60 bp surrounding the PRUNE m 1 A s it e ( GCGGAGGCCGATTCGCCGTGTGGCGGGTTCGAGTCC CGCCTCCTGACTCTGGCCTCTAGTC) followed by firefly luciferase, all driven by a cytomegalovirus promoter. We constructed three derivatives based on this plasmid, point mutating the sequence and structure, as described in the text. These plasmids were pooled together and transfected into cells with either control DNA or with TRMT6/61A overexpression plasmids. The luciferase assay was done with a Promega kit according to the manufacturer's instructions. Code availability. Code for the analyses described in this paper is available from the corresponding author upon request. Data availability. All m 1 A-seq data sets generated in this manuscript have been deposited in the GEO under accession number GSE97419. All other data are available from the corresponding author upon reasonable request. . Shown are the first 500 nt immediately following the transcription start site (left) and immediately preceding the annotated 3′ terminus of the gene (right). Genes are divided into five bins, on the basis of expression levels. b, Distribution of expression levels (on the basis of input samples) of all genes harbouring high-confidence peaks. On this distribution are overlaid, in red, the genes in which putative m 1 A sites were detected. c, Consistently identified peaks are highly enriched towards the 5′ terminus of the gene. Each peak was classified into one of five segments, as in ref. 41 , in the following order: transcription start site (TSS) if the peak is present in the first 200 nt of the gene; 5′ UTR if in the 5′ UTR region but outside the transcription start site region; stop codon region, comprising 200 nt on both sides of the stop window; CDS region for peaks within the CDS; and 3′ UTR for remaining 3′ UTR peaks. Each peak is scored on the basis of the number of experiments in which it was detected, whereby more robustly identified peaks should be considered as ones of higher confidence. The stacked bar plots summarize the relative proportion of peaks in each segment, and the right-most bar plots the relative amount of 'gene architecture' taken up by each of these segments. d, Analysis of transcription start site peaks. The number of reads beginning (rather than overlapping) at each of the first 50 annotated transcribed bases was calculated across IP and input samples (Methods), and the log(fold change) between the two was derived. All fold changes were binned into six bins (as plotted) and the fraction of positions harbouring an ' A' are plotted as a function of this binned fold change, revealing that positions at the transcription start site that are enriched in IP samples over input samples are biased towards beginning with an ' A' . Error bars, binomial error. 
Letter reSeArCH
Data exclusions
Describe any data exclusions.
No data was excluded from analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts to replicate experiments succeeded.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomization was irrelevant for this study.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Irrelevant.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
